← Back to Search

Digital Health Tool for Physical Activity (YourMove Trial)

N/A

Recruiting

Led By Daniel Rivera, PhD

Research Sponsored by University of California, San Diego

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 12 months

Awards & highlights

YourMove Trial Summary

This trial tests a digital health tool to help adults become more physically active over 12 months.

Who is the study for?

This trial is for adults aged 25-80 who are healthy enough to be active, can use a smartwatch and app, and have a BMI of 18-40. They must commit to a year-long program and attend three check-ups. It's not for those in other activity programs, with conditions affecting participation or with devices like pacemakers.Check my eligibility

What is being tested?

The study tests a new mobile health tool that pairs with your phone and watch to boost physical activity over the course of a year. It will be compared against standard digital wellness programs to see if it helps people do more moderate-to-vigorous exercise.See study design

What are the potential side effects?

Since this trial involves increasing physical activity through technology, side effects might include typical exercise-related issues such as muscle soreness or strain but should otherwise have minimal risks.

YourMove Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in minutes of moderate-to-vigorous physical activity (MVPA)

Secondary outcome measures

Anxiety

Change in Body Mass Index (BMI)

Gait

+27 more

Other outcome measures

Alcohol Use Disorder

Smoke

YourMove Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: COT-Based InterventionExperimental Treatment1 Intervention

The COT-based intervention will include the following to improve both steps/day (move more), and improving minutes/week of MVPA (exercise): adaptive daily steps/day goal-setting plus feedback; positive reinforcement (i.e., points, which translate to gift cards), self-monitoring of both steps/day and min/week MVPA; education about MVPA sent via text message in both conditions; planning support for scheduling bouts of MVPA via SMS in both conditions; and motivational messages sent via SMS in both conditions, and the use of a self-experimentation tool (REFLECT), developed based on prior successful pilot efforts, focused on fostering effective self-regulatory capacities of individuals.

Group II: ControlActive Control1 Intervention

The non-COT approach was designed to be an equivalent to emerging standard of care options for digital health worksite wellness programs to increase PA (control) for a 12-month study period. Participants assigned to the non-COT-based (control) group will receive the latest Fitbit Versa smartwatch and will download the Fitbit smartphone app. Unlike the intervention group, the daily step goal and the accompanying number of points will be static (10,000 steps/day; 150 points/day, respectively). The goal will be delivered to participants via the standard Fitbit app features and points will be communicated via email. Participants will also receive a weekly PA goal (150 minutes of MVPA/per week) and the same accompanying motivational and informative texts that the intervention group receives. Control participants will not complete the physical activity and exercise reflection and planning exercise (Reflect).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,664 Previous Clinical Trials

40,925,619 Total Patients Enrolled

5 Trials studying Sedentary Lifestyle

173 Patients Enrolled for Sedentary Lifestyle

Small Steps Labs, LLCUNKNOWN

2 Previous Clinical Trials

718 Total Patients Enrolled

Arizona State UniversityOTHER

283 Previous Clinical Trials

109,128 Total Patients Enrolled

Media Library

COT-Based Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05598996 — N/A

Sedentary Lifestyle Research Study Groups: COT-Based Intervention, Control

Sedentary Lifestyle Clinical Trial 2023: COT-Based Intervention Highlights & Side Effects. Trial Name: NCT05598996 — N/A

COT-Based Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05598996 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who satisfies the criteria to take part in this research?

"This study is recruiting 386 individuals with a sedentary lifestyle, aged 25-80 years old. The primary requirements are: age (25-80), availability for the 12 month trial duration, attendance at 3 measurement visits over the span of one year, proficiency in smartphone and text messaging use, capability to utilize a wearable device and corresponding app, capacity to walk/engage in moderate physical activity as ascertained by Physical Activity Readiness Questionnaire evaluation, BMI between 18-40 kg/m^2."

Answered by AI

What is the current enrollment rate for this trial?

"Affirmative. Based on reports stored within clinicaltrials.gov, this trial is actively enrolling patients. The initial posting was made on October 7th 2022 and the latest update occurred on October 28th 2022;386 participants are expected to be recruited from a single site."

Answered by AI

Does this experiment accept individuals of at least a quarter century in age?

"Eligibility for this research necessitates that participants are between 25 to 80 years of age."

Answered by AI

Are there opportunities available to join this medical experiment?

"Affirmative. According to clinicaltrials.gov, this research study is still accepting patients. It was initially posted on October 7th 2022 and the last update occurred on October 28th of that year. 386 participants are needed at one medical centre for the trial's completion."

Answered by AI